William A. Weiss - Concepedia

Author

William A. Weiss

University of California, San Francisco ORCID

Also Known As

D. Ruggero, J. Phillips, K. Matthay, Lo, Donald C., M. Berger, R. Hashizume, S. Mueller, W A WEISS, W A Weiss, W A. Weiss

813

Publications

35.8K

Citations

H-Index

251

Concepts

All Affiliations

University of California, San Francisco Neurological Surgery UCSF Helen Diller Family Comprehensive Cancer Center Hospital for Sick Children University of Toronto

About

William A. Weiss is an author at University of California, San Francisco specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	138	20.6K
2	Health Sciences	13	16	1.7K
3	Natural Sciences	13	13	6.3K
4	Engineering	5	5	435
5	Nursing	1	1	15

William A. Weiss

223

Publications

29.2K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use and interpretation of assays for monitoring autophagy Daniel J. Klionsky, Fábio Camargo Abdalla, Hagai Abeliovich, Autophagy MitophagyParticular Autophagy AssaysImmunologyCytoskeletonMultiple Assays	2012	4K
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma Brett Johnson, Tali Mazor, Chibo Hong, Science	2013	1.4K
Intertumoral Heterogeneity within Medulloblastoma Subgroups Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek, Cancer Cell BiologyNeuro-oncologyTumor HeterogeneityMedicineSurgical Pathology	2017	1.2K
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling Zachary A. Knight, Beatriz González, Morri E. Feldman, Cell Molecular PharmacologyMetabolic SyndromeSignal TransductionMolecular PhysiologyBiochemistry	2006	1.1K
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells Joachim Silber, Daniel A. Lim, Claudia Petritsch, BMC Medicine	2008	943
Subgroup-specific structural variation across 1,000 medulloblastoma genomes Paul A. Northcott, David Shih, John Peacock, Nature GeneticsGenomicsCancer BiologyTumor BiologyNeuro-oncology	2012	910
Targeted expression of MYCN causes neuroblastoma in transgenic mice William A. Weiss The EMBO Journal GliomaTumor SuppressorTransgenic MiceMedicineCell Biology	1997	865
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition Alexandre Puissant, Stacey M. Frumm, Gabriela Alexe, Cancer Discovery Neuro-oncologyBromodomain InhibitionNovel TherapyOncogenic AgentMycn Transcription	2013	624
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy Stephen C. Mack, Hendrik Witt, Rosario M. Piro, Nature Developmental AnomalyEpigenomic AlterationsDevelopmental BiologyGenetic DisorderMedicine	2014	610
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma Qi-Wen Fan, Zachary A. Knight, David Goldenberg, Cancer Cell Neuro-oncologyGliomaMedicinePharmacologyAnti-cancer Agent	2006	582

Page 1